Periodic paralysis

Jump to: navigation, search
Periodic paralysis
ICD-10 G72.3
ICD-9 359.3

WikiDoc Resources for Periodic paralysis

Articles

Most recent articles on Periodic paralysis

Most cited articles on Periodic paralysis

Review articles on Periodic paralysis

Articles on Periodic paralysis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Periodic paralysis

Images of Periodic paralysis

Photos of Periodic paralysis

Podcasts & MP3s on Periodic paralysis

Videos on Periodic paralysis

Evidence Based Medicine

Cochrane Collaboration on Periodic paralysis

Bandolier on Periodic paralysis

TRIP on Periodic paralysis

Clinical Trials

Ongoing Trials on Periodic paralysis at Clinical Trials.gov

Trial results on Periodic paralysis

Clinical Trials on Periodic paralysis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Periodic paralysis

NICE Guidance on Periodic paralysis

NHS PRODIGY Guidance

FDA on Periodic paralysis

CDC on Periodic paralysis

Books

Books on Periodic paralysis

News

Periodic paralysis in the news

Be alerted to news on Periodic paralysis

News trends on Periodic paralysis

Commentary

Blogs on Periodic paralysis

Definitions

Definitions of Periodic paralysis

Patient Resources / Community

Patient resources on Periodic paralysis

Discussion groups on Periodic paralysis

Patient Handouts on Periodic paralysis

Directions to Hospitals Treating Periodic paralysis

Risk calculators and risk factors for Periodic paralysis

Healthcare Provider Resources

Symptoms of Periodic paralysis

Causes & Risk Factors for Periodic paralysis

Diagnostic studies for Periodic paralysis

Treatment of Periodic paralysis

Continuing Medical Education (CME)

CME Programs on Periodic paralysis

International

Periodic paralysis en Espanol

Periodic paralysis en Francais

Business

Periodic paralysis in the Marketplace

Patents on Periodic paralysis

Experimental / Informatics

List of terms related to Periodic paralysis


Periodic paralysis is a group of rare genetic diseases that lead to weakness or paralysis (rarely death) from common triggers such as cold, heat, high carbohydrate meals, not eating, stress or excitement and physical activity of any kind. The underlying mechanism of these diseases are malfunctions in the ion channels in skeletal muscle cell membranes that allow electrically charged ions to leak in or out of the muscle cell, causing the cell to depolarize and become unable to move (a channelopathy).

It should be noted that the symptoms of periodic paralysis can also be caused by hyperthyroidism; however, if this is the underlying condition there are likely to be other characteristic manifestations, enabling a correct diagnosis.

Types

Periodic paralysis is an autosomal dominant myopathy with considerable variation in penetrance, leading to a spectrum of familial phenotypes (only one parent need carry the gene mutation to affect the children, but not all family members who share the gene are affected to the same degree). Specific diseases include:

  • Paramyotonia congenita (Online Mendelian Inheritance in Man (OMIM) 168300), a form which often accompanies hyperkalemic periodic paralysis, but may present alone. The primary symptom of paramyotonia congenita is muscle contracture which develops during exercise or activity. Paramyotonia congenita attacks may also be triggered by a low level of potassium in the bloodstream. This means people with both hyperkalemic periodic paralysis and paramyotonia congenita can have attacks with fluctuations of potassium up or down.

Diagnosis

This disease is unusually difficult to diagnose. Patients often report years of wrong diagnosis and treatments that made them worse instead of better. Part of this may be that migraines are present in up to 50% of patients and can cause a confusing array of symptoms including headaches, speech difficulties and visual, auditory or sensory auras. DNA testing is available for only a half dozen common gene mutations, while dozens of known mutations are possible but are not routinely tested. EMG results will be normal except during attacks. A properly performed Exercise EMG (Compound Muscle Amplitude Potential Test) can provide an accurate diagnosis in better than 80% of cases. The old glucose/insulin provocative testing can cause life-threatening symptoms and should not be used.

Also of note is that potassium levels do not have to range outside of normal limits to cause serious, even life-threatening paralysis. These diseases are not the same as having a very low level of potassium (hypokalemia) or high potassium (hyperkalemia) and must not be treated as such. The total body store of potassium is usually normal; it is just in the wrong place.

Treatment

Treatment of the periodic paralyses usually includes carbonic anhydrase inhibitors (such as acetazolamide or dichlorphenamide), taking supplemental oral potassium chloride (for hypos) or avoiding potassium (for hypers), thiazide diuretics to manipulate the amount of potassium retained by the kidneys, and significant lifestyle changes including tightly controlled levels of exercise or activity. However, the exact gene mutation, the ion channel affected, and the amount of genetic change or expression can have significant impact on disability and treatment.

Treatment of ATS is similar to that for periodic paralysis, with dichlorphenamide the drug of first choice. Pacemaker insertion or an implantable cardioverter-defibrillator may be required to control cardiac symptoms.

Prognosis

While the disability can range from minor, occasional weakness to permanent muscle damage, inability to hold a normal job and use of a powerchair, most people function fairly well with drugs and lifestyle changes. On a lighter note, people with periodic paralysis are sometimes lovingly called "Possum" because they "play dead" (i.e., become paralyzed) when startled or stressed.

External links



Linked-in.jpg